Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > Datametrex Completed 62,000 COVID-19 Tests in Q2
View:
Post by WalkingDead01 on Jul 08, 2021 8:34am

Datametrex Completed 62,000 COVID-19 Tests in Q2

2021-07-08 08:26 ET - News Release

 

Toronto, Ontario--(Newsfile Corp. - July 8, 2021) -  Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) is pleased to announce that the Company conducted approximately 62,000 COVID-19 tests for the Film and Production industry in Toronto, Vancouver, and Montreal, and sold over 50,000 1 Copy PCR test kits during the second quarter.

"The company is pleased with the testing and sales volume in the COVID-19 business. With the new highly contagious Delta variant spreading around the world, management feels that continued testing will be essential for the immediate future as part of the answer to keep people secure and healthy," said Marshall Gunter, Chief Executive Officer of the Company.

The Company continues to have success with the 1copy™ COVID-19 qPCR Multi Kit, ("1drop"). The manufacturer, 1drop Inc., has confirmed that the 1drop can identify the new variants of the coronavirus that causes COVID-19, now circulating worldwide which is vital to stemming the many variants including the Delta variant that are spreading locally in Canada.

Comment by swyint123888 on Jul 08, 2021 8:42am
Q2 revs will be down a little but still good money, we have 500,000 from AI for the quarter as well, should be a solid 15 million, is it Aug 30 yet
Comment by swyint123888 on Jul 08, 2021 9:01am
Well maybe not 15 million in revs as it looks like test sold dropped by almost 1/3 however this doesn't count one drop sales. They sold over 90,000 tests in Q1 according to one of their NR. Maybe the market picked up on this, Q2 revs may come in at around 13 million if you go strictly by kits sold.....awesome money no question but a negative growth rate Q on Q for sure Toronto, Ontario ...more  
Comment by Leonovus2017 on Jul 08, 2021 9:04am
Good quarter, but again not what Marshall was indicating for a stellar quarter with more tests completed compared to Q1. Too bad the expectation turned out similar to Q1. Decent result though...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities